| http://purl.uniprot.org/citations/31661774 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/31661774 | http://www.w3.org/2000/01/rdf-schema#comment | "Acute kidney injury (AKI) is a common, complex, and severe clinical syndrome characterized by rapid decline in renal function, combined with tissue damage. Currently, the prevention and treatment of AKI are focused on symptomatic treatment, rather than treating the underlying causes. Therefore, there is no specific treatment to prevent renal injury except for renal dialysis. In this study, we used cisplatin-induced AKI mouse and human kidney-2 (HK-2) cell models to evaluate the renal protective effect of eleutheroside B, an active compound in traditional Chinese medicines. MTT assay was used to detect the effect of eleutheroside B on proliferation of human HK-2 cells in presence and in absence of cisplatin. Western blot and immunostaining were used to detect the protein level of kidney injury molecule-1 (KIM-1), cleaved caspase-3, receptor-interacting protein kinase (RIPK)-1, and RIPK-3. Real-time PCR was used to detect the mRNA levels of chemokines (like monocyte chemotactic protein 1, MCP-1) and pro-inflammatory cytokines including interleukin-6 (IL-6) and tumor necrosis factor (TNF-α). Flow cytometry assay was used to detect apoptosis of HK-2 cells. In vivo results showed that eleutheroside B reduced the increase in serum creatinine and blood urea nitrogen (BUN) levels in the AKI model. Periodic acid-Schiff staining and Western blot analysis of KIM-1 showed that eleutheroside B alleviated tubular cell injury. Further, eleutheroside B reduced macrophage infiltration and production of inflammatory cytokines, inhibited the activation of nuclear factor (NF)-κB, and inhibited apoptosis and programmed necrosis. The mechanism may be that eleutheroside B can activate the insulin-like growth factor (IGF) pathway and its downstream pathway by downregulating the expression of IGFBP-7, thus promoting cell proliferation. Therefore, our results suggest that eleutheroside B is a potential drug for AKI treatment."xsd:string |
| http://purl.uniprot.org/citations/31661774 | http://purl.org/dc/terms/identifier | "doi:10.3390/molecules24213876"xsd:string |
| http://purl.uniprot.org/citations/31661774 | http://purl.uniprot.org/core/author | "Li J."xsd:string |
| http://purl.uniprot.org/citations/31661774 | http://purl.uniprot.org/core/author | "Yang Q."xsd:string |
| http://purl.uniprot.org/citations/31661774 | http://purl.uniprot.org/core/author | "Zang H."xsd:string |
| http://purl.uniprot.org/citations/31661774 | http://purl.uniprot.org/core/date | "2019"xsd:gYear |
| http://purl.uniprot.org/citations/31661774 | http://purl.uniprot.org/core/name | "Molecules"xsd:string |
| http://purl.uniprot.org/citations/31661774 | http://purl.uniprot.org/core/pages | "E3876"xsd:string |
| http://purl.uniprot.org/citations/31661774 | http://purl.uniprot.org/core/title | "Eleutheroside B Protects against Acute Kidney Injury by Activating IGF Pathway."xsd:string |
| http://purl.uniprot.org/citations/31661774 | http://purl.uniprot.org/core/volume | "24"xsd:string |
| http://purl.uniprot.org/citations/31661774 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/31661774 |
| http://purl.uniprot.org/citations/31661774 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/31661774 |
| http://purl.uniprot.org/uniprot/#_A0A5E1-mappedCitation-31661774 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/#_F8WH23-mappedCitation-31661774 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/#_Q3U131-mappedCitation-31661774 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/#_Q61581-mappedCitation-31661774 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/#_Q811C8-mappedCitation-31661774 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/#_Q3UFA6-mappedCitation-31661774 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/Q3UFA6 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/F8WH23 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/Q61581 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/Q811C8 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/Q3U131 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31661774 |
| http://purl.uniprot.org/uniprot/A0A5E1 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31661774 |